By comparing the available data, 68GaFAPI-04 PET/CT appears to show a higher detection rate for bone metastases in various malignancies compared with 18FFDG PET/CT. However, this finding should be interpreted with caution, as pooled sensitivity, specificity, PPV, NPV, DOR, or HSROC analyses could not be performed due to insufficient available data.
He et al. (Fri,) studied this question.